End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
84.05 EUR | -2.66% |
|
-1.20% | -14.83% |
06-05 | CARL ZEISS MEDITEC AG : Goldman Sachs reiterates its Sell rating | ZD |
05-31 | Carl Zeiss Meditec just above annual low - JPMorgan skeptical | DP |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With an expected P/E ratio at 29.59 and 23.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.56 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.83% | 8.07B | - | ||
+7.77% | 218B | B | ||
+10.16% | 189B | B- | ||
+26.21% | 151B | B- | ||
+32.78% | 113B | A- | ||
+1.98% | 64.02B | A- | ||
+14.48% | 52.6B | B+ | ||
+2.92% | 49.85B | B+ | ||
-6.60% | 37.89B | A | ||
-1.07% | 34.92B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AFX Stock
- AFX Stock
- Ratings Carl Zeiss Meditec AG